TITLE

SYSTOLIC HYPERTENSION AND CARDIAC MORTALITY OF TAKAYASU'S AORTOARTERITIS

AUTHOR(S)
Swinton Jr., Neil W.; Cook, Guillermo A.
PUB. DATE
October 1976
SOURCE
Angiology;Oct1976, Vol. 27 Issue 10, p568
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Long-term observations of a 35-year-oId woman who died from refractory congestive heart failure due to Takayasu's aortoarleritis are reported. Severe systolic hypertension was documented in the prepulseless phase. After the loss of all limb pulses, but relative sparing of carotid vessels. serial ophthalmodynametric retinal pressures suggested that central aortic pressure remained high during her terminal cardiac illness. Postmortem pathologic examination showed a narrowed, severely atherosclerotic aorta with variable occlusions of all branch vessels. The loss of capacitance and volume of the aorta appears to be the cause of systolic hypertension and refractory pump failure of the left ventricle.
ACCESSION #
16352577

 

Related Articles

  • Neonatal renovascular hypertension due to prenatal traumatic retroperitoneal hematoma. Dixon, Bradley; Devarajan, Prasad; Mitsnefes, Mark // Pediatric Nephrology;May2005, Vol. 20 Issue 5, p670 

    This report describes severe hypertension in a 7-week-old male infant found to have renovascular disease from an organized hematoma due to prenatal trauma. As such, this case illustrates a novel acquired, congenital mechanism of renovascular hypertension. The importance of considering prenatal...

  • Severe Dyspnea and Anuria May Be Associated With Inflammatory Aneurysm -- A Case History. Mulder, Erik J.; Sier, Johannes C. // Vascular Surgery;Sep1993, Vol. 27 Issue 7, p561 

    A fifty-seven-year-old man presented with severe hypertension and congestive heart disease due to bilateral ureteric obstruction as a result of retroperitoneal fibrosis around a dilatated abdominal aorta. Current views on etiology and treatment of this condition--the "inflammatory" aneurysm--are...

  • How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction? MacFadyen, R. J.; Goyal, D; Lip, G. Y. H. // Journal of Human Hypertension;Dec2005, Vol. 19 Issue 12, p919 

    The article provides view of the author on the link between hypertension and left ventricular systolic heart failure. The distinction between these classification that are not well delineated in epidemiology of systolic left ventricular dysfunction, is only one of the issues that influence any...

  • Do beta-blockers worsen respiratory status for patients with COPD? Baselli, Lynda M.; Oswald, Mark A.; Nasheisky, Joan M. // Journal of Family Practice;May2005, Vol. 54 Issue 5, p472 

    The article presents information on patients with chronic obstructive pulmonary disease (COPD) who use cardio-selective beta-blockers. These patients do not experience a significant worsening of their short-term pulmonary status as measured by changes in forced expiratory volume in 1 second or...

  • The Digital Circulation in Congestive Heart Failure. Burch, George E. // Angiology;Mar1983, Vol. 34 Issue 3, p151 

    Congestive heart failure (CHF) is a complex clinical entity which is still little understood pathophysiologically. Unless it is in the intractable state it responds well to therapy. It has been known for many years that the peripheral circulation can be dramatically altered when CHF is...

  • Obstrüktif uyku apne sendromu Åžiddeti ile hipertansiyon arasጞndaki iliÅžki. Bayram, Nihal Akar; Çiftçi, Bülent; Güven, Selma Fırat; Bayram, Hüseyin; Diker, Erdem // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Dec2007, Vol. 7 Issue 4, p378 

    Objective: Obstructive sleep apnea syndrome (OSAS) is a syndrome defined frequently by decrease in arterial oxygen saturation and repeated upper airway obstruction episodes during sleep. The most important complications of OSAS patients belong to cardiovascular system. Systemic arterial...

  • Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction. Sanganalmath, Santosh K.; Barta, Judit; Takeda, Nobuakira; Kumamoto, Hideo; Dhalla, Naranjan S. // Canadian Journal of Physiology & Pharmacology;Apr2008, Vol. 86 Issue 4, p180 

    Antiplatelet agents such as sarpogrelate (SAR), a 5-hydroxytryptamine antagonist, and cilostazol (CIL), a phosphodiesterase-III inhibitor, are used in the management of peripheral vascular disease. In this study, we tested the hypothesis that both SAR and CIL prevent cardiac remodeling and...

  • Protective approaches against myocardial ischemia reperfusion injury (Review). XIANCHI LI; MIN LIU; RONGRONG SUN; YI ZENG; SHUANG CHEN; PEIYING ZHANG // Experimental & Therapeutic Medicine;Dec2016, Vol. 12 Issue 6, p3823 

    Myocardial ischemia-reperfusion is the leading cause for the events of cardiovascular disease, and is considered as a major contributor to the morbidity and mortality associated with coronary occlusion. The myocardial damage caused by ischemia-reperfusion injury constitutes the primary...

  • Pain Free 1-2-3!: D-Ribose - Fantastic in Congestive Heart Failure and Other Cardiac Problems. Teitelbaum, Jacob // Townsend Letter;Jul2007, Issue 288, p146 

    The article offers information about the therapeutic benefits of D-Ribose, a dietary supplement which aids in treating congestive heart failure and other cardiac problems. Studies show that Ribose could aid as a therapeutic option for cardiovascular disease since it enhances the detection of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics